142 related articles for article (PubMed ID: 38452744)
1. The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation.
Buelli S; Imberti B; Morigi M
Nephron; 2024 Mar; ():. PubMed ID: 38452744
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
3. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
4. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins.
Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y
Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960
[TBL] [Abstract][Full Text] [Related]
5. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
6. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
7. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
8. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
11. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Peng Q; Li K; Sacks SH; Zhou W
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
[TBL] [Abstract][Full Text] [Related]
12. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
[TBL] [Abstract][Full Text] [Related]
13. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
15. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
16. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
17. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
18. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
[TBL] [Abstract][Full Text] [Related]
20. The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-κB signaling.
Luo S; Xu H; Gong X; Shen J; Chen X; Wu Z
Exp Ther Med; 2022 Aug; 24(2):493. PubMed ID: 35837068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
